The infection surveillance solutions market is set to reach US$ 934.7 Mn in 2026 from US$ 330.7 Mn in 2017 projecting excellent growth at a CAGR of 12.4% from 2018 to 2026. As per the latest research citing provided by World Health Organization (WHO), in the near future glooming threat of hospital acquired infection and rampant growth in antibiotic resistance by microbes will result in increased mortality worldwide. There is need to monitor and supervise infectious disease in real time mode.
Market Synopsis
Get a sample copy for more information
"Provision of real time surveillance and rampant growth in the IT-healthcare industry drive the software market growth"
Software solutions are leading the product segment for infection surveillance solutions market. The major parameters that influence its growth are its ability to provide real time surveillance of infectious disease and rampant growth in IT-healthcare industry. Web based solutions are gaining immense popularity owing to availability in different configurations and immediate return on initial investment. On-premise software solutions are feasible in hospitals owing to low maintenance cost incurred and low subscription fee. Services segment will growth at a steady pace during the forecast period owing to entry of large number of market participants willing to provide outsourcing solutions related to infection surveillance.
Get a sample copy for more information
"Prolonged use of catheters and increasing number of patients with suppressed immune system drive the urinary tract infection market growth"
Urinary tract infection are reigning the type segment for infection surveillance solutions market. Increasing number of patients suffering with suppressed immune system and prolonged use of catheters drive the market growth for urinary tract infection. It is more susceptible in the women population in comparison to men. Others segment comprises of infections caused by pneumonia causing microbes and methicillin resistant staphylococcus aureus bacteria. They will register growth at a rapid pace on account of significant rise in hospital acquired infections worldwide.
"Increasing number of inbound patients and significant rise in the number of surgeries performed drive the hospitals market growth"
In the present scenario hospitals are dominating the end-use segment for infection surveillance solutions market. The key factors that determine its outstanding growth are increasing number of inbound patients and rise in the number of surgeries performed. Lon term care centers will witness fast growth during the forecast period from 2018 to 2026, owing to its ability to antimicrobial resistance infection and increasing outbound patients due to low healthcare cost incurred.
Get a sample copy for more information
"Rising prevalence of hospital acquired infection (HAI) and existence of excellent healthcare framework drive the market growth in North America"
Currently North America holds 35% share in the regional segment for global infection surveillance solutions market. The important parameters that are responsible for the excellent market growth in North America are existence of excellent healthcare framework and rising prevalence of hospital acquired infection. Presence of pioneering IT-healthcare companies specializing in providing infection surveillance solutions such as Truven Health Analytics, Becton Dickinson & Company and Baxter International, Inc. etc. further consolidate the market growth in North America. Europe is the second largest regional market accounting for 30% share owing to proactive government policy in fighting infectious disease and enhanced funding in the research and development segment to counteract microbial resistance issue. Asia Pacific represents 20% market share and will be registering steady growth on account of presence of large patient pool suffering with hospital acquired infection and rising public health awareness regarding infectious disease.
Historical & Forecast Period
This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.
Report Scope by Segments
Infection surveillance solutions market segmentation is as follows:
| ATTRIBUTE |
DETAILS |
| Research Period |
2016-2026 |
| Base Year |
2017 |
| Forecast Period |
2018-2026 |
| Historical Year |
2016 |
| Unit |
USD Million |
| Segmentation |
By Product (2016–2026; US$ Mn)
• Services
• Software
|
|
By Type (2016–2026; US$ Mn)
• Urinary Tract Infection
• Surgical Site Infection
• Blood Stream Infection
• Others
|
|
By End-Use (2016–2026; US$ Mn)
• Hospitals
• Long Term Care Centers
• Others
|
|
Geography Segment (2016–2026; US$ Mn)
• North America (U.S. and Canada)
• Europe (U.K., Germany, and Rest of Europe)
• Asia Pacific (Japan, China,and Rest of Asia Pacific)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Middle East and Africa (GCC, Rest of MEA)
|
IT-healthcare companies pioneering in providing infection surveillance solutions are Becton Dickinson and Company, Deb Group, Ltd., Gojo Industries, Inc., Baxter International, Inc., Truven Health Analytics, Hygreen, Inc., Premier, Inc., Atlas Medical Software, RL Solutions and Wolters Kluwer N.V.
Key questions answered in this report
- Which are the major IT-healthcare companies providing infection surveillance solutions?
- What is the global mortality rate associated with hospital acquired infection and antibiotic resistance by bacteria?
- What is the role of software solution in monitoring infectious disease?
- What is the disease etiology associated with urinary tract infection?
- What is the healthcare burden incurred by hospitals related to infectious disease?
- Why is North America the leading regional segment in infection surveillance solutions market?
